Products
Preparation registered in Ukraine
Bezdetko P.
Kharkiv National Medical University, Kharkiv, Ukraine
What is myopia? A look at the nature of the clinical course and some aspects of pharmacological treatment
Abstract
The paper presents data on the frequency and types of myopiasation of the eye and myopia. Specific features of scleral changes and the formation of myopic staphylomas are described in detail using modern informative methods of OCT and 3D MRT. A logical chain of changes on the fundus is presented, based on the results of modern studies and recommendations of the latest photographic classification of myopic maculopathy. The directions of pharmacological support of myopes, including the use of muscarinic receptor antagonists for strengthening sclera and preventing the progression of lengthening of the anterior-posterior axis of the eye, are substantiated. The use of antioxidants, carotenoids, anthocyanosides and Omega-3 PSFA in myopes has been substantiated, and the necessity of this type of treatment for preventing the formation of choroidal neovascularization in myopes has been substantiated. The need for anti-VEGF drugs in the treatment of myopic choroidal neovascularization.
Keywords: myopia, pathological myopia, posterior staphyloma, myopic maculopathy, mosaic eye fundus, “lacquer” cracks, patchy chorioretinal atrophy, myopic choroidal neovascularization, muscarinic receptor inhibitors, antioxidants, carotenoids, anti-VEGF drugs.